The global Anatomic Pathology Market size reached a valuation of USD 32.5 Billion in 2022 and is likely to grow at a robust CAGR of 8.2% between 2022 and 2030, surpassing USD 61.1 Billion by the end of 2030. Growth in the global anatomic pathology market is driven by the rising application of anatomic pathology in disease diagnosis and drug discovery and development.
| Attribute | Details |
|---|---|
| Anatomic Pathology Market Size (2022) | USD 32.5 Billion |
| Anatomic Pathology Market Revenue Forecast (2030) | USD 61.1 Billion |
| Anatomic Pathology Market Growth Rate (2022 to 2030) | 8.2% CAGR |
| North America Market Share | 37.1% |
Anatomic pathology is a medical specialty that focuses on identifying diseases based on microscopic, macroscopic, immunologic, biochemical, and molecular examinations of organs and tissues. Its (anatomical pathology) main role is to identify abnormalities that can help to diagnose disease and manage treatment.
The adoption of anatomic pathology has shown promising results in identifying and managing various types of tumors or cancers, kidney and liver diseases, autoimmune disorders, etc. As a result, it is often being used in end-use verticals such as hospitals, research laboratories, and diagnostic laboratories.
The rising prevalence of numerous diseases coupled with the growing need for early detection of chronic diseases and the rapidly expanding healthcare industry is providing a strong thrust to the growth of the anatomic pathology market and the trend is likely to continue during the forecast period.
Consequently, increasing usage of biomarkers advances in histology, and rapid expansion of the cellular pathology market will positively impact the anatomic pathology market projections in the future.
Over the years, biomarkers have become quite popular as they allow pathologists to determine disease causation at the molecular level, which aids clinical decision-making and improves patient outcomes.
Currently, anatomic pathology accounts for a 0.2% share of the global pathology market and this number is expected to increase substantially on account of rising applications of anatomic pathology in numerous applications.
Regionally, North America will continue to dominate the global anatomic pathology market, accounting for around 37.1% share through 2030.
Growth in the North American anatomic pathology market is driven by the strong presence of major market players, favorable government policies connected to pathological training programs, availability of advanced technologies, favorable reimbursement scenarios for anatomic pathology diagnostic tests, and rising healthcare expenditures
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 8.21% |
| H1, 2022 Projected | 8.20% |
| H1, 2022 Outlook | 7.80% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 40 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 41 ↓ |
The comparative analysis and market growth rate of global anatomic pathology market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 40 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 41 Basis Point Share (BPS).
The key developments in the market include the design of Biophotonics in pathology to describe various types of imaging methods available. This factor has enforced the factor of pathology and radiology to converge towards a more holistic approach to diagnostic imaging, thus playing as a major driving factor for growth of the market.
The market observes a decline in the BPS values owed to the decreased flexibility in work force staffing, when compared with general service providers such as laboratories, high operational costs and overheads with each unit of subspecialty operating, and a greater need for trained staff, among others.
Several new approaches, such as cryoelectron tomography, holographic tissue dynamics spectroscopy, cellular magnetic resonance imaging, exotic material lensing, and photoacoustic tomography are further set to propel the market growth over the coming years.
The global demand for anatomic pathology products and services is projected to grow at a healthy CAGR of 8.2% during the forecast period between 2022 and 2030, totaling over USD 61.1 Billion by 2030.
Factors such as the rising prevalence of cancer and other target diseases, growing demand for personalized medicine, escalating need for early diagnosis of chronic diseases, surge in R&D activities, and introduction of favorable reimbursement policies are driving the anatomic pathology industry growth.
Anatomic pathology has become one of the most commonly used techniques for the detection and management of diseases like cancer. It allows pathologists to determine the cause and effect of particular diseases by analyzing tissues and organs during biopsies and other medical procedures.
The rapid surge in cancer cases across the globe is providing a major impetus to the growth of the anatomic pathology market and the trend is likely to continue during the forecast period.
According to the American Cancer Society, it is estimated that the global cancer burden is expected to grow to 27.5 billion new cancer cases and 16.3 million cancer deaths by 2040. This will create immense demands for advanced diagnostic technologies and treatment approaches, thereby expanding the anatomic pathology market size.
Furthermore, advancements in anatomic pathology instruments will significantly aid in improving the anatomic pathology market share during the forecast period.
Leading anatomic pathology manufacturers are continuously focusing on introducing advanced digital products such as specimen tracking systems (STS), to empower anatomical pathologists to accurately diagnose diseases and make confident treatment decisions.
Additionally, growing awareness, increasing healthcare expenditure, escalating cancer research, and a rise in the use of biomarkers during illness diagnosis will boost the anatomic pathology market growth during the forthcoming years.
Based on the aforementioned factors, FMI’s latest report on the anatomic pathology market forecasts the global anatomic pathology market to expand at 1.88X by 2030.
Principal Consultant
Despite its optimistic stance, the global anatomic pathology market is facing various obstacles that are challenging its growth to some extent. Some of these obstacles include the availability of refurbished anatomic pathology equipment, frequent product recalls, and the adoption of alternative diagnostic techniques.
Today, various refurbished anatomic pathology devices such as tissue processors, microtomes, and staining systems are available from LabX (US), Rankin Biomedical Corporation (US), Swerdlick Medical Systems (US), and AL-TAR (US).
The availability of these refreshed anatomic pathology products is expected to negatively impact the revenue of companies selling branded anatomic pathology devices.
Rising Investments in Research and Development Creating Space for Anatomic Pathology Market Growth in the USA
As per FMI, the USA is expected to account for a significant share of the global anatomic pathology market through 2030, owing to the rising prevalence of cancer, high research, and development funding, availability of favorable reimbursement policies, increasing adoption of pathology imaging systems, surge in anatomic pathology labs, flourishing human anatomical models market, and strong presence of leading anatomic pathology m market players.
Over the years, the USA has become a global leader in medical research. The country annually spends billions of dollars on research and development to advance personalized medicine and reduce the burden of chronic diseases. For instance, the National Institutes of Health (NIH) alone spends about USD 41.7 billion annually on medical research for the American people.
Similarly, a rise in the number of new anatomic pathology product launches and approvals will improve the anatomic pathology market share of the USA during the forecast period.
Availability of Advanced Pathology Devices and Increasing Number of Anatomic Pathology Service Providers Spurring Growth in the Germany Anatomic Pathology Market
With the rising prevalence of chronic diseases and the availability of advanced pathology devices, the anatomic pathology market in Germany is expected to grow at a strong CAGR during the forecast period between 2022 and 2030.
As the burden of cancer and other chronic diseases across Germany continues to rise, medical institutes and government organizations are putting various efforts to tackle the situation. They are increasingly investing in advanced diagnostic technologies to improve diagnostic screening and reduce healthcare burden. This is creating a conducive environment for the anatomic pathology industry growth in the country.
The European anatomic pathology market, spearheaded by Germany and the UK is expected to account for 25.7% of the global market share.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Demand for Anatomic Pathology Services to Remain High Throughout the Forecast Period
As per FMI, the anatomic pathology services segment is likely to account for the largest share of the global anatomic pathology market during the forecast period, owing to the rapid surge in cancer cases, availability of favorable reimbursement for diagnostic tests, and increase in the number of anatomic pathology service providers worldwide.
Disease Diagnosis Segment to Contribute Most to the Global Anatomic Pathology Market
Based on application, the global anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. Among these, the disease diagnosis segment accounted for the largest share in 2021, and is likely to grow at a relatively higher CAGR during the assessment period, as per the latest anatomic pathology market trends.
This can be attributed to the rising incidence of cancer and other chronic diseases, the growing need for early diagnosis of these diseases to initiate proper treatment, and various initiatives launched by the government to facilitate diagnostic screening of chronic diseases.
Similarly, the expansion of the cancer tissue diagnostics market and advancements in tissue diagnostics will support the growth of this segment during the forthcoming years.
Demand for Anatomic Pathology Products and Services to Remain High in Hospitals
Based on end users, the anatomic pathology market has been segmented into hospitals, research laboratories, diagnostic laboratories, and others.
As per FMI, the hospital segment held the largest share of the anatomic pathology market in 2021 and the trend is likely to continue during the forecast period, owing to the rising number of patient visits to hospitals, growing awareness among people regarding the importance of early diseases diagnosis, and rapid increase in the number of hospitals worldwide.
Some of the leading anatomic pathology providers include Laboratory Corporation of America Holdings, F.Hoffmann-La Roche AG, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics, Bio SB, and Agilent Technologies.
Players like Roche have become global leaders in solutions for anatomical pathology labs to diagnose cancers. They are continuously investing in research and development to advance personalized healthcare and integrate digital tools in anatomic pathology. For instance,
Similarly, various leading players are adopting strategies like new product launches, acquisitions, mergers, partnerships, and collaborations to gain a competitive edge in the global anatomic pathology market. For instance,
Future Market Insights latest report provides a detailed anatomic pathology market forecast for a period of 8 years (2022 to 2030). It examines how advancement in anatomic pathology is revolutionizing the disease diagnosis and drug discovery services markets
The report is intended to enlighten customers with significant details about market shaping factors including drivers, restraints, emerging opportunities and latest anatomic pathology market trends.
While developed nations like the United States, Germany, and the United Kingdom remain at the top of the ladder, factors pushing anatomic pathology industry growth across emerging economies such as India and China have been thoroughly discussed.
FMI also illustrates how rise in chronic diseases and increasing investments in R&D will expand the global anatomic pathology market size during the forthcoming years. Besides this, it offers insights into leading anatomic pathology manufacturers and their growth strategies.
The Anatomic Pathology Market Analysis Includes:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2030 |
| Historic Data Available for | 2015 to 2021 |
| Market Analysis | USD Billion for Value |
| Report Coverage | Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
| Key Segments Covered |
Product & Service, Application, End User, Region |
| Key regions covered |
North America (USA, Canada, Rest of North America); Latin America (Brazil, Argentina, Mexico, Rest of Latin America); Western Europe (Germany, UK, France, Rest of Western Europe); Eastern Europe (Russia, Spain, Rest of Eastern Europe); South Asia Pacific (China, India, Japan, Malaysia, Thailand, Indonesia, South Korea, Rest of South Asia & Pacific); Middle East & Africa GCC Countries (Turkey, Israel, Rest of MEA); Rest of the World (Oceania, Africa, South America) |
| End User |
Hospitals, Research Laboratories, Diagnostic Laboratories, Others |
| Key companies profiled | Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Sakura Finetek USA; Inc.; F.Hoffmann-La Roche AG; Cardinal Health; Inc.; BioGenex; NeoGenomics; Bio SB; Agilent Technologies |
| Customization & pricing | Available upon request |
As per FMI, the global anatomic pathology market was valued at USD 32.5 Billion in 2022.
The global anatomic pathology market is expected to grow at 8.2% CAGR during the forecast period between 2022 to 2030.
The anatomic pathology market is projected to reach USD 61.1 Billion by 2030.
Laboratory Corporation of America Holdings, Sakura Finetek USA, Inc., BioGenex, Quest Diagnostics Incorporated, F.Hoffmann-La Roche AG, Cardinal Health, Inc., NeoGenomics, and Bio SB are some of the leading players operating in anatomic pathology market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Market Context 5. Market Background 6. Global Anatomic Pathology Market: Pricing Analysis 7. Global Anatomic Pathology Market Demand (in Value or Size in USD Billion) Analysis 2015 to 2021 and Forecast, 2022 to 2030 8. Global Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030, By Product 9. Global Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030, By Application 10. Global Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030, By End User 11. Global Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. East Asia 11.5. South Asia 11.6. Oceania 11.7. Middle East and Africa (MEA) 12. North America Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030 13. Latin America Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030 14. Europe Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030 15. South Asia Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030 16. East Asia Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030 17. Oceania Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030 18. Middle East and Africa (MEA) Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030 19. Key and Emerging Countries Anatomic Pathology Market Analysis 2015 to 2021 and Forecast 2022 to 2030 20. Market Structure Analysis 21. Competition Analysis 21.1. F. Hoffmann-La Roche Ltd 21.2. Danaher Corporation 21.3. Hologic Inc. 21.4. Thermo Fisher Scientific, Inc. 21.5. Agilent Technologies, Inc. 21.6. NeoGenomics 21.7. Cardinal Health, Inc. 21.8. Gestalt Diagnostics 21.9. Inspirata Inc. 21.10. Laboratory Corporation of America Holdings 21.11. Nichirei Bioscience (Nichirei Corporation) 21.12. BioGenex 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Anatomic Pathology Market
